- Filed
- Mar 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2025 · Mar 14, 2025 | 34.36M sh |
| Shares Diluted | FY 2025 · Dec 29, 2023 | 22.36K sh |
| Capex | FY 2025 · Dec 29, 2023 | $7.04M |
| Operating Cash Flow | FY 2025 · Dec 29, 2023 | −$88.1M |
| Long Term Debt | FY 2025 · Dec 29, 2023 | $29.63M |
| Cash And Equivalents | FY 2025 · Dec 29, 2023 | $62.94M |
| Current Liabilities | FY 2025 · Dec 29, 2023 | $271.25M |
| Total Liabilities | FY 2025 · Dec 29, 2023 | $356.16M |
| Current Assets | FY 2025 · Dec 29, 2023 | $257.46M |
| Total Assets | FY 2025 · Dec 29, 2023 | $426.65M |
| Eps Diluted | FY 2025 · Dec 29, 2023 | −$0.11 |
| Eps Basic | FY 2025 · Dec 29, 2023 | −$0.11 |
| Sga Expense restated | FY 2025 · Dec 29, 2023 | $64.13M |
| Net Income | FY 2025 · Dec 29, 2023 | −$2.55M |
| Operating Income | FY 2025 · Dec 29, 2023 | $435K |
| Gross Profit | FY 2025 · Dec 29, 2023 | $22.37M |
| Cost Of Revenue | FY 2025 · Dec 29, 2023 | $610.43M |
| Revenue | FY 2025 · Dec 29, 2023 | $632.81M |
| Stockholders Equity | FY 2025 · Dec 30, 2022 | $51.6M |